Alcor News Bulletin
                Number 17: October 1st 2003

This bulletin is sent via email to anyone who has requested
it. Please do not reply to this message; the news server at does not receive email. Send any comments,
suggestions, or complaints to the new address that has been
established to deal with human communications:


Subscribe/unsubscribe information is at the end of this

The layout of Alcor News is best viewed using a monospaced
font such as Courier. 

                    A Brief Interim Report

This is just a brief report, to keep Alcor's friends and members 
informed of our latest activities.


Charles Platt

Charles Platt has decided for a variety of reasons, many of them 
personal, to end his contractual work relationship with Alcor for 
now.  We would like to thank him for all he has done to improve 
the quality of care here at Alcor and for his stewardship of 
AlcorNews, to wish him luck in his future activities, and to 
assure him that any future proposals to work with Alcor will be 
warmly welcomed.  AlcorNews will continue in the physical format 
it has always had, as a cooperative venture of the staff and 


Tanya Jones

This week, Tanya Jones started work as Director of Clinical Services.  
She held this position for several years in the early to mid 90's, 
and is now returning "tanned, rested, and ready".  She is one of 
the most experienced cryonicists in the world, and she has assisted 
in recent cases on a consulting basis.  Welcome back, Tanya.


Larry Johnson

Like all legal matters, this progresses at a very slow pace, so 
don't be surprised if there is little or no news we can report.  
All we can say is that Mr. Johnson has responded to our lawsuit, and 
has filed a counter-suit of his own.  Because of pending litigation,
Alcor cannot comment on any allegations made by Mr. Johnson. 
Alcor will continue to pursue all legal remedies available to it.
We also respectfully request that people avoid public speculation
based on incomplete news stories.

Readers may be worried about how these things have affected and will 
affect Alcor. The short answer is one of reassurance. Alcor's services
and capabilities are not presently threatened, nor does it seem likely
they will be.  Our patients are secure and our membership can be
confident we can be there when needed.  This is not to say there haven't
been difficulties.  There have been, but we believe we are coping with
them well, and our ability to respond to emergencies remains strong.  
Details will be forthcoming in Cryonics Magazine.


New Web Site!

We are proud to announce the launching of Alcor's new website.  A 
Website Working Group composed of Stephen Van Sickle, Kevin Q. Brown,
David Brandt-Erichsen, and Brian Wilson has been assembled to create 
the new site, building on a large amount of programming previously 
done by Kevin Q. Brown.  The website is based on the graphic design 
of Bobby June, with updates on the content and graphics by Charles 
Platt.  It is at the same location:

that it always was, but is new and improved.  It is not quite as showy
and flashy as the previous site, but has a serious professional look
that loads very quickly.  No long waits for those with dial-up 
connections.  But the big improvement, the one we have been working 
hard on, is a vast increase in online content.  Back issues of Cryonics
Magazine from 1981 to 1992 are available, with more editions coming as
they are available.  Many of the best articles, reports, and essays from
over the years are likewise available in the Library section. This is
just the beginning...we have many more ideas to expand the site, and it
changes every day.  It is still very much under construction.  Come
visit, and visit often as we grow.  If you have any comments or
suggestions, feel free to send them to  The website
is still in flux, so please hold any substantial remarks until the site
stabilizes in a few weeks.  You may find we fixed your complaint without
even asking us!


CEO Search

We are continuing our search for a new CEO/General Manager for 
Alcor.  A notice detailing the job requirements has been circulating:

Alcor is a non-profit 501(c)3 corporation located in 
Scottsdale, Arizona. Founded in 1972, it is the world's 
largest provider of cryonic suspension services (the 
experimental practice of preserving legally deceased persons 
for possible future recovery). Its purposes are to maintain 
members who are already in cryonic suspension, to provide 
state-of-the-art service for members when they require 
cryonic suspension, and to further research and public 
education in the field. For more information, please see our 

The successful candidate will:

Have an understanding and acceptance of the priorities set 
forth in our mission statement.

Enough generalized business experience to make day to day 
operational decisions and spending decisions appropriate to 
our financial circumstances, as well as familiarity with the 
legal and regulatory environment in which small businesses 
and non-profits operate.

Enough technical understanding to supervise and evaluate 
our medical staff on an ongoing basis, and to coordinate 
their efforts during patient standbys, transports and 
cryonic suspensions. 

Competence to make decisions regarding
patient care and suspension services when cases are imminent

High level written and verbal communication skills, 
including the ability to represent Alcor in the mass media.

If you are interested in applying, please submit your resume & salary
requirements by email only to:

Please place "AlcorNews" in the subject line of your email.


Dr. Jerry Lemler Speaks at Cambridge University

The International Association of Biomedical Gerontology held its 
tenth congress or conference (IAGB 10) 19-23 September at Queens 
College, Cambridge UK. Quoting from the conference Website 
( The purpose of the IABG is 
(1) to make the general public more aware of the potential of 
biomedical aging research to increase the span of healthy productive 
life and to decrease the social and economic problems of age; and 
(2) to promote greater communication among the worldwide community 
of individuals engaged in biomedical aging research. The conference 
title was: Strategies for Engineered Negligible Senescence: reasons 
why genuine control of aging may be foreseeable.

The main organizer, Dr. Aubrey de Grey, is highly regarded in 
gerontology and anti-aging research. He is avidly promoting and 
pursuing his concept of engineered negligible senescence--essentially, 
the end of the aging process. He is optimistic and enthusiastic, yet
also a realist, and well aware of the problem that, for many if not most
people now living, a cure for aging will likely come too late. Thus he
is also interested in cryonics, and serves on Alcor's Scientific 
Advisory Board. He spoke at Alcor's conference last November, and 
gave space for Dr. Jerry Lemler to speak on cryonics at IAGB 10. 

Dr. Lemler's talk will be published in the Annals of the New York 
Academy of Sciences later this year.  The abstract of his talk 


If one accepts the feasibility of engineering negligible senescence,
the benefits of the endeavor depend on when it succeeds. Many of those
who would like to benefit from engineered negligible senescence will
likely perish before it can be accomplished. There is, however, a
potential safety net for such individuals, which can be called medical
time travel. It is based on one fact and two assumptions. The fact is
that at the boiling point of liquid nitrogen, changes in biological
systems are generally agreed to be negligible for periods of hundreds to
thousands of years. The first assumption is that it is possible to cool
a human being to such a temperature without fundamentally destroying the
essential information in the brain. The second assumption is that
medical and scientific progress will continue until medical
resuscitation technology is limited only by physical law. If these
assumptions are correct, the memories and personalities of people
preserved by today's methods should be intact after revival by future
technology, and medical time travel can be used as a bridge to a time in
which senescence can be controlled. Based on presently available
information, the evidence in support of both assumptions of this
proposal appears to be strong.

Dr. Lemler, who is currently undergoing chemotherapy for cancer, is to
be especially thanked for making what must have been an arduous plane
trip from Arizona to the UK.

To subscribe to Alcor News, visit and
follow instructions on the web site, or send a blank piece of
email to alcornews with the single word


in the subject line. You will receive email asking you to
verify your request for Alcor News.

To Unsubscribe or change your email address, visit and alter your preferences. 


Alcor News is written by the staff of the Alcor Foundation.
Contents are copyright 2003 by Alcor Foundation but permission 
is granted to reprint any whole news item, so long as Alcor 
is credited as the source and the reprint includes our URL at